2019 AFib Guidelines Made Simple Tool
Section 4.1.1 - Selection of Antithrombotic Regimen Section 6.1.1 - Prevention of Thromboembolism I IIa IIb III Oral anticoagulants recommended for high risk patients now include edoxaban. Exclusion criteria for CHA 2 DS 2-VASc assessment and use of NOACs now defined as moderate to severe mitral stenosis or a mechanical heart valve. ................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
- curriculum vitae personal information charles marc samama
- antitrombotická léčba tromboembolické žilní nemoci
- diagnostika a léčba tromboembolické nemoci z pohledu 10
- american academy of orthopaedic surgeons peer review
- personal information charles marc samama
- managing anticoagulation patients in the hospital the
- accp american
- anticoagulation updated guidelines for outpatient management
- antithrombotic therapy and prevention of thrombosis 9th
- vte 2016 accp update with best evidence and best practices